SFS
BIO icon

Sowell Financial Services’s Bio-Rad Laboratories Class A BIO Stock Holding History

Sowell Financial Services’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-553
Closed -$333K – 778
2021
Q1 		$333K Buy
553
+470
+566% +$278K 0.01% 795
2020
Q4 		$48K Sell
83
-95
-53% -$54.1K ﹤0.01% 1416
2020
Q3 		$92K Sell
178
-100
-36% -$50.6K ﹤0.01% 995
2020
Q2 		$126K Buy
278
+180
+184% +$79.4K 0.01% 894
2020
Q1 		$34K Sell
98
-54
-36% -$19.9K ﹤0.01% 1179
2019
Q4 		$56K Buy
152
+148
+3,700% +$52.2K ﹤0.01% 1118
2019
Q3 		$1K Buy
+4
New +$1.3K ﹤0.01% 2196

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return